title: Is age associated with the development of antibodies against botulinum toxin?
authors.forename: M V
authors.initials: MV
authors.lastname: Aun
authors.forename: T M
authors.initials: TM
authors.lastname: Chung
authors.forename: K S
authors.initials: KS
authors.lastname: Santos
authors.forename: L M R
authors.initials: LM
authors.lastname: Battistella
authors.forename: L V
authors.initials: LV
authors.lastname: Rizzo
authors.forename: J
authors.initials: J
authors.lastname: Kalil
authors.forename: P
authors.initials: P
authors.lastname: Giavina-Bianchi
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000907:Antibodies, Bacterial / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D019274:Botulinum Toxins, Type A / Q000276:immunology* / Q000627:therapeutic use; D047013:Clostridium botulinum type A / Q000276:immunology*; D004351:Drug Resistance / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000276:immunology* / Q000627:therapeutic use; D010291:Paresis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D015415:Biomarkers; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA